PI Industries (PIIND) is currently trading around ₹3,310–3,320 per share (NSE close on 12 December 2025), with a 52‑week range of approximately ₹2,951–₹4,804 and a TTM P/E near 30–35x, which is a premium to the agrochemicals sector average. (insights.market)

No one can reliably state what “price it will be” at a future date. What can be shared is how the market is currently valuing it and what professional analysts are projecting, which are only scenarios, not guarantees.

1. What analysts are indicating (examples, not advice)

Recent institutional and brokerage research on PI Industries suggests varied 12‑month target prices, broadly in this zone:

- Motilal Oswal: Buy, target about ₹4,260. (moneycontrol.com)

- Jefferies: Buy, target around ₹4,120–₹4,315 in recent notes. (livemint.com)

- Citi: Buy, target about ₹4,400. (tipranks.com)

- Morgan Stanley: Buy, target raised up to ₹5,000. (in.investing.com)

- Some other coverage (e.g., TipRanks aggregation) shows an average target in the ₹3,600–₹4,100 range, depending on which set of analysts and date you look at. (tipranks.com)

These targets typically imply a potential upside in the low‑ to mid‑teens (%) from recent prices, but they are only estimates and can change quickly with new data.

2. Key drivers that will decide the future price

Where PIIND actually trades over the next 6–18 months will mainly depend on:

- Earnings growth and guidance:

- The company recently cut FY25 revenue growth guidance from mid‑teens to high single digits due to global agrochem headwinds. This has already hurt sentiment and led to sharp drawdowns after results. (tradingview.com)

- CSM (contract manufacturing) and pharma ramp‑up:

- A large part of value comes from long‑term CSM contracts and the newer pharma segment; faster execution here can support higher valuations. (moneycontrol.com)

- Global agro‑chem cycle:

- Industry weakness or inventory overhang globally can cap near‑term revenues and margins, pressuring the stock. (tradingview.com)

- Valuation re‑rating/de‑rating:

- At ~30–35x earnings, any disappointment in growth can lead to P/E compression and downside; if growth re‑accelerates, the premium can sustain or expand. (insights.market)

3. How to think about it for yourself (illustrative only)

- If earnings growth re‑accelerates and meets the more optimistic broker assumptions, the stock could move closer to some of the higher targets (₹4,200–₹5,000) over 12–18 months.

- If growth stays weak or guidance is cut further, the market could compress the P/E multiple towards sector levels, which would mean limited upside or even meaningful downside from current levels.

These are only illustrative scenarios, not predictions or recommendations. Always align any decision with your risk profile, time horizon, and diversification, and consider consulting a SEBI‑registered advisor before acting.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com